Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles
Clinical trial NCT05139121 · COMPLETED
Trial details
- NCT number
- NCT05139121
- Sponsor
- Mylan Technologies Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-26
- Primary completion
- 2025-01-15
- Enrollment
- 1319
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.